October 24, 2016 5:24 AM ET

Diversified Consumer Services

Company Overview of University of California, Irvine

Company Overview

University of California, Irvine is a research and scholarship university that offers undergraduate and graduate degree courses. The university operates colleges including The Claire Trevor School of the Arts, School of Biological Sciences, The Henry Samueli School of Engineering, Graduate School of Management, UCI Medical Center, and University Research Park. It offers degree courses in arts and humanities, environment and energy, health and medicine, science and business, and society and culture. University of California, Irvine was founded in 1965 and is based in Irvine, California. University of California, Irvine operates as a subsidiary of University of California.

510 Aldrich Hall

Irvine, CA 92697-1900

United States

Founded in 1965





Key Executives for University of California, Irvine

Dean of Law School
Dean of Continuing Education
Age: 63
Director of Marketing and Communications
Compensation as of Fiscal Year 2016.

University of California, Irvine Key Developments

UC Irvine Names Leigh Poirier as Program Director for the New UCI+One Program

University of California, Irvine has reported the appointment of Leigh Poirier as the program director of UCI+One. The new program is designed to prepare undergraduate alumni for life after graduation, which includes preparation for future career choices, guidance in applying for graduate schools and internships, getting started in areas of public service and how to pursue meaningful post-graduate travel. As program director, Poirier, along with her team will oversee the program's success to ensure UCI undergraduates continue to pursue long-lasting impacts beyond school. Poirier has been the director of the UCI Graduate Resource Center and a faculty member at Orange Coast College. In addition, she's also participated as associated director and interim director of the UCI Health Education Center.

University of California, Irvine Extension Appoints Ian Gibson as Director of Law and Finance Programs

University of California, Irvine Extension, the continuing education unit of UC Irvine, announced the appointment of Ian Gibson, Esq. as the director of law and finance programs. Gibson will oversee the development and promotion of new legal and financial programs, as well as the continued management and optimization of department resources and policies to ensure that all curriculum components complement today's marketplace needs. Prior to joining UC Irvine Extension, Gibson was a practicing civil attorney with One LLP. Gibson's legal practice primarily focused on litigation and transactional matters in copyright, trademark, and entertainment law. He represented a broad variety of clients including internationally known illustrators, photographers, film production companies, musicians, and technology firms. In addition, Gibson also serves as a founding member of the Board of Directors for 1888 and promotion of cultural heritage and literary arts in Orange County.

Biocept and University of California, Irvine to Study Blood-Based Liquid Biopsy Testing in Cancer Patients

Biocept Inc. announced a collaboration with the University of California, Irvine to evaluate biomarkers detected from blood-based versus invasive tissue biopsies in patients with metastatic cancers. The collaboration is aimed at validating the use of liquid biopsies to qualify patients for available targeted therapies and to establish a framework for serial monitoring of tumor mutations during cancer treatment to help identify early indicators of resistance to therapy. The National Comprehensive Cancer Network (NCCN) guidelines recommend testing of key biomarkers in patients with lung cancer such as EGFR, ALK and ROS1. Test results from these biomarkers are used to qualify patients for targeted therapies that have demonstrated improved survival, such as Roche’s Tarceva® for patients with EGFR+ lung cancer and Pfizer’s Xalkori® for patients with ALK+ lung cancer. Current testing methods rely on tumor tissue from invasive biopsy and/or surgical tissue removal. Both procedures can entail significant patient risk and healthcare expense. Further, tissue biopsies can fail to contain adequate tumor tissue for biomarker analyses. In these instances, it is believed that a blood-based liquid biopsy, such as those offered by Biocept, can provide accurate biomarker information to better guide therapy.

Similar Private Companies By Industry

Company Name Region
1-800-Dryclean, LLC United States
1-800-PHONESEX United States
125 Max Drycleaning Center LLC United States
180 Skills LLC United States
19Pencils, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University of California, Irvine, please visit www.uci.edu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.